120 related articles for article (PubMed ID: 7905676)
1. Sequencing analysis of Ha-, Ki-, and N-ras genes in rat urinary bladder tumors induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) and sodium saccharin.
Masui T; Mann AM; Borgeson CD; Garland EM; Okamura T; Fujii H; Pelling JC; Cohen SM
Teratog Carcinog Mutagen; 1993; 13(5):225-33. PubMed ID: 7905676
[TBL] [Abstract][Full Text] [Related]
2. Point mutation in codons 12 and 61 of the Ha-ras gene in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Masui T; Mann AM; Garland EM; Okamura T; Johansson PL; Cohen SM
Mol Carcinog; 1990; 3(4):210-5. PubMed ID: 2206284
[TBL] [Abstract][Full Text] [Related]
3. H-ras mutations in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and sodium saccharin, sodium ascorbate, or related salts.
Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Fujii H; Pelling JC; Cohen SM
Cancer Res; 1991 Jul; 51(13):3471-5. PubMed ID: 2054786
[TBL] [Abstract][Full Text] [Related]
4. Activating missense mutations in Ha-ras-1 genes in a malignant subset of bladder lesions induced by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-[4-(5-nitro-2-furanyl)-2-thiazolyl]formamide.
Jones RF; Debiec-Rychter M; Zukowski K; Wang CY
Mol Carcinog; 1990; 3(6):393-402. PubMed ID: 2278634
[TBL] [Abstract][Full Text] [Related]
5. Direct DNA sequencing of the rat neu oncogene transmembrane domain reveals no mutation in urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or N-methyl-N-nitrosourea.
Masui T; Mann AM; Macatee TL; Garland EM; Okamura T; Smith RA; Cohen SM
Carcinogenesis; 1991 Oct; 12(10):1975-8. PubMed ID: 1682063
[TBL] [Abstract][Full Text] [Related]
6. Ras involvement in cells transformed with 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) in vitro and with N-[4-(5-nitro-2-furyl)-2-thiazoyl]formamide in vivo.
Mann AM; Asamoto M; Chlapowski FJ; Masui T; Macatee TL; Cohen SM
Carcinogenesis; 1992 Sep; 13(9):1651-5. PubMed ID: 1394851
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats.
Sakata T; Hasegawa R; Johansson SL; Zenser TV; Cohen SM
Cancer Res; 1986 Aug; 46(8):3903-6. PubMed ID: 3731063
[TBL] [Abstract][Full Text] [Related]
8. Effect of sodium phenobarbital and sodium saccharin in AIN-76A diet on carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and N,N-dibutylnitrosamine in male F344 rats.
Imaida K; Wang CY
Cancer Res; 1986 Dec; 46(12 Pt 1):6160-4. PubMed ID: 3779637
[TBL] [Abstract][Full Text] [Related]
9. Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Fukushima S; Friedell GH; Jacobs JB; Cohen SM
Cancer Res; 1981 Aug; 41(8):3100-3. PubMed ID: 7248968
[TBL] [Abstract][Full Text] [Related]
10. Enhanced immunoreactivity of ras oncogene p21 protein in urinary bladder epithelium of rats treated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Masui T; Ward JM; Cohen SM
Cancer Lett; 1991 Aug; 59(2):95-102. PubMed ID: 1884376
[TBL] [Abstract][Full Text] [Related]
11. Absence of ras oncogene activation in rat urinary bladder carcinomas induced by N-methyl-N-nitrosourea or N-butyl-N-(4-hydroxybutyl)nitrosamine.
Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Smith RA; Cohen SM
Carcinogenesis; 1992 Dec; 13(12):2281-5. PubMed ID: 1473235
[TBL] [Abstract][Full Text] [Related]
12. p53 mutation is infrequent and might not give a growth advantage in rat bladder carcinogenesis in vivo.
Asamoto M; Mann AM; Cohen SM
Carcinogenesis; 1994 Mar; 15(3):455-8. PubMed ID: 8118928
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of Harvey-ras oncogene in FANFT-induced transitional cell carcinoma.
Sawczuk IS; Walsh W; King W; Olsson CA; Nguyen-Huu C
Urol Int; 1987; 42(5):321-5. PubMed ID: 3433577
[TBL] [Abstract][Full Text] [Related]
14. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Yamamoto S; Masui T; Murai T; Mori S; Oohara T; Makino S; Fukushima S; Tatematsu M
Carcinogenesis; 1995 Oct; 16(10):2363-8. PubMed ID: 7586136
[TBL] [Abstract][Full Text] [Related]
15. Neu is not involved in N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide- induced bladder carcinoma or 2-amino-4-(5-nitro-2-furyl)thiazole transformation of rat bladder epithelial cells.
Mann AM; Asamoto M; Masui T; Macatee T; Eklund SH; Cohen SM
Cancer Lett; 1994 Aug; 84(1):7-13. PubMed ID: 7915640
[TBL] [Abstract][Full Text] [Related]
16. Co-carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide for the urinary bladder.
Murasaki G; Cohen SM
Carcinogenesis; 1983; 4(1):97-9. PubMed ID: 6821891
[TBL] [Abstract][Full Text] [Related]
17. Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis.
Cohen SM; Arai M; Jacobs JB; Friedell GH
Cancer Res; 1979 Apr; 39(4):1207-17. PubMed ID: 421204
[TBL] [Abstract][Full Text] [Related]
18. Comparative bladder tumor promoting activity of sodium saccharin, sodium ascorbate, related acids, and calcium salts in rats.
Cohen SM; Ellwein LB; Okamura T; Masui T; Johansson SL; Smith RA; Wehner JM; Khachab M; Chappel CI; Schoenig GP
Cancer Res; 1991 Apr; 51(7):1766-77. PubMed ID: 2004360
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an N-methyl-N-nitrosourea-induced autochthonous rat bladder cancer model.
Steinberg GD; Brendler CB; Ichikawa T; Squire RA; Isaacs JT
Cancer Res; 1990 Oct; 50(20):6668-74. PubMed ID: 2208131
[TBL] [Abstract][Full Text] [Related]
20. Lack of bladder tumor promoting activity in rats fed sodium saccharin in AIN-76A diet.
Okamura T; Garland EM; Masui T; Sakata T; St John M; Cohen SM
Cancer Res; 1991 Apr; 51(7):1778-82. PubMed ID: 2004361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
